EUVIMEDScopri EUVIMED
Open access

Prevalence and factors associated with liver fibrosis among first‐degree relatives of Mexican Americans with hepatocellular carcinoma

Suzanne Sharpton, Kuangda Shan, Ricki Bettencourt, Miryoung Lee, Joseph B McCormick, Susan P Fisher-Hoch, Rohit Loomba iD

Alimentary Pharmacology & Therapeutics · 2023

DOI: 10.1111/apt.17384 ↗

At a glance

Journal article in Alimentary Pharmacology & Therapeutics, 2023. Written by Suzanne Sharpton and 6 co-authors. Institution: Division of Gastroenterology, Hepatology and Nutrition, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Major MEDLINE topics: Carcinoma, Hepatocellular, Non-alcoholic Fatty Liver Disease, Liver Neoplasms, Elasticity Imaging Techniques. Cited 10 times so far (Crossref); 46 references. The full text is freely available in PubMed Central. Funded by: NCATS NIH HHS, NIEHS NIH HHS, NIDDK NIH HHS.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Background and Aims Whether hepatocellular carcinoma (HCC) increases the familial risk for hepatic fibrosis has not been thoroughly explored, particularly in Mexican Americans who are disproportionately affected by obesity and metabolic syndrome. We evaluated the risk of significant hepatic fibrosis in first‐degree relatives of Mexican American adults with HCC.

Methods

We performed a cross‐sectional analysis of a prospective cohort of Mexican American probands with HCC and first‐degree relatives enrolled in the Hispanic Liver Cancer Cohort study. We evaluated the prevalence of hepatic fibrosis in first‐degree relatives, defined by liver stiffness measurement (LSM) >= 7.0 kPa with transient elastography (TE). Secondary outcomes included the prevalence of definite hepatic steatosis, defined by controlled attenuation parameter >=288 dB/m.

Results

We identified 70 probands diagnosed with HCC; 47% were female and the mean age was 62 years (±13 years). Among 112 first‐degree relatives with a mean age of 43 years (±14 years), 19 (17%) had significant fibrosis and 47 (42%) had definite hepatic steatosis, respectively. The prevalence of significant fibrosis was 20% in first‐degree relatives 40 years of age or older. Regression analysis revealed that diabetes (OR 3.2, 95% CI: 1.1–9.2, p = 0.03) and aspartate aminotransferase >=30 units/L (OR 4.0, 95% CI: 1.4–11.7, p = 0.01) were predictors of significant fibrosis in first‐degree relatives.

Conclusions

Using a well‐phenotyped familial cohort, we found that the prevalence of significant fibrosis and definite hepatic steatosis are high in first‐degree relatives of Mexican Americans with HCC, particularly those with diabetes, suggesting that this population may benefit from screening for liver disease.

Subjects

MeSH terms (MEDLINE)

Carcinoma, HepatocellularNon-alcoholic Fatty Liver DiseaseLiver NeoplasmsElasticity Imaging TechniquesAdultHumansFemaleMiddle AgedMaleMexican AmericansCohort StudiesProspective StudiesPrevalenceCross-Sectional StudiesLiver CirrhosisLiver

Author keywords

elastographyfamilial riskfatty liverfibrosisliver stiffness

Authors and institutions

  • Division of Gastroenterology, Hepatology and Nutrition, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Department of Medicine, NAFLD Research Center, University of California, San Diego, La Jolla, California, USA.
  • Department of Epidemiology, Genetics and Environmental Sciences, University of Texas School of Public Health, Brownsville, Texas, USA.
  • Division of Gastroenterology, University of California, San Diego, La Jolla, California, USA.
  • Department of Family Medicine and Public Health, Division of Epidemiology, University of California, San Diego, La Jolla, California, USA.

ORCID profiles: Rohit Loomba

Funding

  • NCATS NIH HHS
  • NIEHS NIH HHS
  • NIDDK NIH HHS
  • NIAAA NIH HHS
  • NHLBI NIH HHS
  • Center for Clinical and Translational Sciences, University of Texas Health Science Center at Houston
  • National Center for Advancing Translational Sciences
  • National Institute of Environmental Health Sciences

Cite

APA

Sharpton, S., Shan, K., Bettencourt, R., Lee, M., McCormick, J. B., Fisher-Hoch, S. P., & Loomba, R. (2023). Prevalence and factors associated with liver fibrosis among first‐degree relatives of Mexican Americans with hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.17384

Vancouver

Sharpton S, Shan K, Bettencourt R, Lee M, McCormick JB, Fisher-Hoch SP, et al. Prevalence and factors associated with liver fibrosis among first‐degree relatives of Mexican Americans with hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics. 2023. doi:10.1111/apt.17384

BibTeX
@article{Sharpton2023,
  author = {Sharpton, Suzanne and Shan, Kuangda and Bettencourt, Ricki and Lee, Miryoung and McCormick, Joseph B and Fisher-Hoch, Susan P and Loomba, Rohit},
  title = {Prevalence and factors associated with liver fibrosis among first‐degree relatives of Mexican Americans with hepatocellular carcinoma},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2023},
  doi = {10.1111/apt.17384}
}
Start for free →